Raul R. Gainetdinov

Citée par

	Toutes	Depuis 2019
Citations	46950	14749
indice h	103	60
indice i10	243	205

3500

1750

875

2625

19992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024204 368 483 659 870 996 1177 1306 1349 1696 1517 1687 1978 2022 2141 2130 2286 2828 3430 2633 2550 2529 3076 3152 2677 741

Accès public

Tout afficher

78 articles

3 articles

disponibles

non disponibles

Sur la base des exigences liées au financement

Coauteurs

Jean Martin BeaulieuDepartment of Pharmacology and Toxicology, University of TorontoAdresse e-mail validée de utoronto.ca
Stefano EspinozaPostdoc, Italian Institute of TechnologyAdresse e-mail validée de iit.it
Damiana LeoMons UniversityAdresse e-mail validée de iit.it
Sara JonesProfessor, Department of Physiology and Pharmacology, Wake Forest School of MedicineAdresse e-mail validée de wakehealth.edu
Laura M. Bohn, PhDThe Herbert Wertheim UF Scripps Biomedical Institute for Technology & InnovationAdresse e-mail validée de ufl.edu
R. Mark WightmanProfessor of Chemistry, University of North Carolina at chapel hillAdresse e-mail validée de unc.edu
Ilya SukhanovFirst Pavlov State Medical Univercity of Saint PetersburgAdresse e-mail validée de iit.it
Robert J. LefkowitzJames B. Duke Professor of Medicine, Biochemistry, Chemistry; HHMI, Duke UniversityAdresse e-mail validée de receptor-biol.duke.edu
Fabio FumagalliUniversità Degli Studi di MilanoAdresse e-mail validée de unimi.it
Xiaodong ZhangDuke-NUS Graduate Medical School SingaporeAdresse e-mail validée de duke-nus.edu.sg
Ali SalahpourAssociate Professor, Department of Pharamcology and Toxicology, University of TorontoAdresse e-mail validée de utoronto.ca
Marius C. HoenerPh.D., Distinguished Scientist, Head of Exploratory Biology, Drug Discovery Project Team LeaderAdresse e-mail validée de roche.com
Richard T PremontHarrington Discovery Institute, Case, Duke, Mt SinaiAdresse e-mail validée de case.edu
Gary Wright MillerProfessor of Environmental Health Sciences, Columbia UniversityAdresse e-mail validée de cumc.columbia.edu
Amy RamseyAssociate Professor, University of TorontoAdresse e-mail validée de utoronto.ca
Miguel NicolelisProfessor Emeritus Neurobiology Duke UniversityAdresse e-mail validée de neuro.duke.edu
Vania BroccoliCNR-Institute of Neuroscience-San Raffaele HospitalAdresse e-mail validée de hsr.it
Maria Teresa Dell'AnnoFondazione Pisana per la ScienzaAdresse e-mail validée de fpscience.it
Ramona RodriguizResearch Associate, PhD, Assistant Director Mouse Behavioral Core, Duke UniversityAdresse e-mail validée de mc.duke.edu
Fabio BenfenatiFull professor of Neurophysiology, University of Genova, Director Center for Synaptic Neuroscience and Technology, Istituto Italiano di TecnologiaAdresse e-mail validée de iit.it

Suivre

Raul R. Gainetdinov

Institute of Translational Biomedicine St. Petersburg State University

Adresse e-mail validée de spbu.ru

Pharmacology Neuroscience


Titre Trier par citations Trier par année Trier par titre	Citée par Citée par	Année
The physiology, signaling, and pharmacology of dopamine receptors JM Beaulieu, RR Gainetdinov Pharmacological reviews 63 (1), 182-217, 2011	3192	2011
Mice with reduced NMDA receptor expression display behaviors related to schizophrenia AR Mohn, RR Gainetdinov, MG Caron, BH Koller Cell 98 (4), 427-436, 1999	1302	1999
Plasma membrane monoamine transporters: structure, regulation and function GE Torres, RR Gainetdinov, MG Caron Nature Reviews Neuroscience 4 (1), 13-25, 2003	1257	2003
Direct generation of functional dopaminergic neurons from mouse and human fibroblasts M Caiazzo, MT Dell’Anno, E Dvoretskova, D Lazarevic, S Taverna, D Leo, ... Nature 476 (7359), 224-227, 2011	1235	2011
Enhanced morphine analgesia in mice lacking β-arrestin 2 LM Bohn, RJ Lefkowitz, RR Gainetdinov, K Peppel, MG Caron, FT Lin Science 286 (5449), 2495-2498, 1999	1228	1999
An Akt/β-arrestin 2/PP2A signaling complex mediates dopaminergic neurotransmission and behavior JM Beaulieu, TD Sotnikova, S Marion, RJ Lefkowitz, RR Gainetdinov, ... Cell 122 (2), 261-273, 2005	1167	2005
μ-Opioid receptor desensitization by β-arrestin-2 determines morphine tolerance but not dependence LM Bohn, RR Gainetdinov, FT Lin, RJ Lefkowitz, MG Caron Nature 408 (6813), 720-723, 2000	1109	2000
Role of serotonin in the paradoxical calming effect of psychostimulants on hyperactivity RR Gainetdinov, WC Wetsel, SR Jones, ED Levin, M Jaber, MG Caron science 283 (5400), 397-401, 1999	1036	1999
Desensitization of G protein–coupled receptors and neuronal functions RR Gainetdinov, RT Premont, LM Bohn, RJ Lefkowitz, MG Caron Annu. Rev. Neurosci. 27, 107-144, 2004	1028	2004
Lithium antagonizes dopamine-dependent behaviors mediated by an AKT/glycogen synthase kinase 3 signaling cascade JM Beaulieu, TD Sotnikova, WD Yao, L Kockeritz, JR Woodgett, ... Proceedings of the National Academy of Sciences 101 (14), 5099-5104, 2004	926	2004
Tryptophan hydroxylase-2 controls brain serotonin synthesis X Zhang, JM Beaulieu, TD Sotnikova, RR Gainetdinov, MG Caron Science 305 (5681), 217-217, 2004	846	2004
Profound neuronal plasticity in response to inactivation of the dopamine transporter SR Jones, RR Gainetdinov, M Jaber, B Giros, RM Wightman, MG Caron Proceedings of the National Academy of Sciences 95 (7), 4029-4034, 1998	812	1998
Mechanisms of amphetamine action revealed in mice lacking the dopamine transporter SR Jones, RR Gainetdinov, RM Wightman, MG Caron Journal of Neuroscience 18 (6), 1979-1986, 1998	803	1998
The Concise Guide to PHARMACOLOGY 2019/20: G protein‐coupled receptors SPH Alexander, A Christopoulos, AP Davenport, E Kelly, A Mathie, ... British journal of pharmacology 176, S21-S141, 2019	741	2019
Cocaine self-administration in dopamine-transporter knockout mice BA Rocha, F Fumagalli, RR Gainetdinov, SR Jones, R Ator, B Giros, ... Nature neuroscience 1 (2), 132-137, 1998	694	1998
Loss-of-function mutation in tryptophan hydroxylase-2 identified in unipolar major depression X Zhang, RR Gainetdinov, JM Beaulieu, TD Sotnikova, LH Burch, ... Neuron 45 (1), 11-16, 2005	632	2005
Physiological roles of G protein–coupled receptor kinases and arrestins RT Premont, RR Gainetdinov Annu. Rev. Physiol. 69, 511-534, 2007	625	2007
Dopamine receptors–IUPHAR Review 13 JM Beaulieu, S Espinoza, RR Gainetdinov British journal of pharmacology 172 (1), 1-23, 2015	616	2015
Akt/GSK3 signaling in the action of psychotropic drugs JM Beaulieu, RR Gainetdinov, MG Caron Annual review of pharmacology and toxicology 49, 327-347, 2009	611	2009
Hyperactivity and impaired response habituation in hyperdopaminergic mice X Zhuang, RS Oosting, SR Jones, RR Gainetdinov, GW Miller, MG Caron, ... Proceedings of the National Academy of Sciences 98 (4), 1982-1987, 2001	574	2001

Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.

Articles 1–20

Nombre de citations par an

Citations en double

Citations fusionnées

Ajouter les coauteursCoauteurs

Suivre

Citée par

Coauteurs